Encore Capital Group Valuation
Is ECPG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ECPG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ECPG ($48.62) is trading above our estimate of fair value ($3.3)
Significantly Below Fair Value: ECPG is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ECPG?
Key metric: As ECPG is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is ECPG's PS Ratio? | |
|---|---|
| PS Ratio | 0.9x |
| Sales | US$1.33b |
| Market Cap | US$1.16b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.4x |
| Enterprise Value/EBITDA | 12.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ECPG's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.1x | ||
PRAA PRA Group | 0.8x | 8.5% | US$895.0m |
ATLC Atlanticus Holdings | 2x | 38.0% | US$730.9m |
PRG PROG Holdings | 0.8x | 4.7% | US$2.0b |
TREE LendingTree | 0.7x | 10.8% | US$580.3m |
ECPG Encore Capital Group | 0.9x | 14.9% | US$1.2b |
Price-To-Sales vs Peers: ECPG is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (1.1x).
Price to Sales Ratio vs Industry
How does ECPG's PS Ratio compare vs other companies in the US Consumer Finance Industry?
Price-To-Sales vs Industry: ECPG is good value based on its Price-To-Sales Ratio (0.9x) compared to the US Consumer Finance industry average (1.6x).
Price to Sales Ratio vs Fair Ratio
What is ECPG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.9x |
| Fair PS Ratio | 3.3x |
Price-To-Sales vs Fair Ratio: ECPG is good value based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (3.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$48.62 | US$62.25 +28.0% | 4.3% | US$65.00 | US$58.00 | n/a | 4 |
| Nov ’25 | US$45.79 | US$61.00 +33.2% | 3.7% | US$64.00 | US$58.00 | n/a | 4 |
| Oct ’25 | US$46.09 | US$60.25 +30.7% | 5.6% | US$64.00 | US$55.00 | n/a | 4 |
| Sep ’25 | US$50.08 | US$60.25 +20.3% | 5.6% | US$64.00 | US$55.00 | n/a | 4 |
| Aug ’25 | US$48.31 | US$61.00 +26.3% | 10.5% | US$70.00 | US$52.00 | n/a | 4 |
| Jul ’25 | US$41.68 | US$61.00 +46.4% | 10.5% | US$70.00 | US$52.00 | n/a | 4 |
| Jun ’25 | US$44.24 | US$61.00 +37.9% | 10.5% | US$70.00 | US$52.00 | n/a | 4 |
| May ’25 | US$41.78 | US$60.75 +45.4% | 10.5% | US$70.00 | US$52.00 | n/a | 4 |
| Apr ’25 | US$43.52 | US$60.75 +39.6% | 10.5% | US$70.00 | US$52.00 | n/a | 4 |
| Mar ’25 | US$48.89 | US$60.75 +24.3% | 10.5% | US$70.00 | US$52.00 | n/a | 4 |
| Feb ’25 | US$51.26 | US$59.00 +15.1% | 13.9% | US$73.00 | US$52.00 | n/a | 4 |
| Jan ’25 | US$50.75 | US$59.00 +16.3% | 13.9% | US$73.00 | US$52.00 | n/a | 4 |
| Dec ’24 | US$45.32 | US$59.00 +30.2% | 13.9% | US$73.00 | US$52.00 | n/a | 4 |
| Nov ’24 | US$37.43 | US$63.25 +69.0% | 9.8% | US$73.00 | US$56.00 | US$45.79 | 4 |
| Oct ’24 | US$47.76 | US$63.25 +32.4% | 9.8% | US$73.00 | US$56.00 | US$46.09 | 4 |
| Sep ’24 | US$47.43 | US$63.25 +33.4% | 9.8% | US$73.00 | US$56.00 | US$50.08 | 4 |
| Aug ’24 | US$52.90 | US$63.25 +19.6% | 9.8% | US$73.00 | US$56.00 | US$48.31 | 4 |
| Jul ’24 | US$48.62 | US$63.25 +30.1% | 9.8% | US$73.00 | US$56.00 | US$41.68 | 4 |
| Jun ’24 | US$43.33 | US$63.25 +46.0% | 9.8% | US$73.00 | US$56.00 | US$44.24 | 4 |
| May ’24 | US$51.05 | US$64.00 +25.4% | 10.7% | US$73.00 | US$56.00 | US$41.78 | 4 |
| Apr ’24 | US$50.45 | US$64.00 +26.9% | 10.7% | US$73.00 | US$56.00 | US$43.52 | 4 |
| Mar ’24 | US$52.87 | US$64.00 +21.1% | 10.7% | US$73.00 | US$56.00 | US$48.89 | 4 |
| Feb ’24 | US$55.29 | US$62.25 +12.6% | 14.3% | US$73.00 | US$50.00 | US$51.26 | 4 |
| Jan ’24 | US$47.94 | US$62.25 +29.8% | 14.3% | US$73.00 | US$50.00 | US$50.75 | 4 |
| Dec ’23 | US$50.93 | US$62.25 +22.2% | 14.3% | US$73.00 | US$50.00 | US$45.32 | 4 |
| Nov ’23 | US$50.98 | US$71.00 +39.3% | 15.3% | US$87.00 | US$58.00 | US$37.43 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
IX
JP¥108.63
7D
-2.1%
1Y
19.6%
Federal Home Loan Mortgage
US$9.7b
Operates in the secondary mortgage market in the United States.
FMCC
US$3.29
7D
49.0%
1Y
422.6%
VEF
SEK 2.3b
A venture capital firm specializing in early venture, emerging growth and growth capital investments.
VEFF.F
SEK 0.20
7D
0%
1Y
n/a